Oil prices have recently climbed above US$113 per barrel as Middle East risks disrupt supply routes and push energy costs higher. That kind of shock often reshapes where capital flows next, as investors look for businesses with strong growth engines and sturdy finances. This article focuses on a group of high potential Australian growth stocks and highlights three candidates from that list that analysts expect to deliver rapid earnings and revenue growth.
The three stocks profiled next are just a small sample, with the full screen surfacing 31 more high growth potential companies with equally compelling stories that are not covered below. To go straight to the source, use the Best high growth potential screener to identify, filter and analyze the ideas that best fit your own conviction level.
Resolute Mining (ASX:RSG)
Overview:Resolute Mining is a Perth based gold producer focused on African operations, with the Doropo Gold Project anchoring its growth plans.
Operations:Resolute Mining currently generates most of its revenue from the Syama mine in Mali at about $696 million and the Mako mine in Senegal at around $307 million.
Market Cap:A$2.4 billion
Resolute Mining fits this high growth screen because it already runs producing African gold assets while preparing Doropo as the next major leg of its expansion. This gives investors exposure to an existing cash engine alongside a clearly defined project that is intended to push earnings higher if everything goes to plan.
"The build out of Doropo following its mining permit and final investment decision, with construction progressing through land clearing, road building and ordering of key plant, is expected to add a large new source of ounces from 2028 and can materially increase group revenue and operating profit.
What matters now is how one unresolved cost and execution pressure ultimately shapes the margin profile investors are counting on.
That margin question is exactly what the full narrative for Resolute Mining unpacks in plain English, including how Doropo could reshape Resolute Mining if execution and costs line up.
Neuren Pharmaceuticals (ASX:NEU)
Overview:Neuren Pharmaceuticals develops and commercializes treatments for neurological disorders, with DAYBUE and NNZ‑2591 at the center of its high growth potential story.
Operations:Neuren Pharmaceuticals currently generates about A$69 million from commercial products, with all reported revenue sourced from the United States.
Market Cap:A$2.5 billion
Neuren Pharmaceuticals matters in this high growth screen because DAYBUE is already on the market while NNZ‑2591 pushes a second potential growth leg closer to commercial reality.
"The expectation of increased diagnosed population and patient uptake of DAYBUE in the U.S. indicates potential revenue growth with more patients getting access to the drug."
What really moves the needle now is how one long running clinical and commercialization effort ultimately shapes the earnings power you are paying for.
That earnings power question is exactly what the full narrative for Neuren Pharmaceuticals pulls apart, mapping how DAYBUE momentum and NNZ‑2591 trial risk could reshape Neuren Pharmaceuticals' trajectory.
Lynas Rare Earths (ASX:LYC)
Overview:Lynas Rare Earths mines and processes rare earth minerals, turning Mt Weld ore into magnet materials that feed electric vehicles and wind turbines.
Operations:Lynas Rare Earths currently generates about A$978 million in revenue from its rare earth operations segment.
Market Cap:A$11.5 billion
Lynas Rare Earths matters for this high growth screen because its integrated Mt Weld, Kalgoorlie and Gebeng assets connect directly into rising demand for rare earth magnets powering electrification.
"Investors appear to expect sustained above-trend pricing and demand, largely based on the belief that Western governments' ongoing support for supply chain diversification and critical mineral security will continue to provide Lynas Rare Earths with long-term government-backed offtake agreements and pricing floors, which could support future revenue and valuation multiples."
What really decides how far that growth story runs is how one large capital and cost burden eventually filters through into long term margins.
Those margin swings are exactly what the full narrative for Lynas Rare Earths unpacks, showing where Lynas Rare Earths could see earnings accelerate or where pressure could quietly build.
Curious About What You Might Be Missing?
Fresh ideas with real momentum do not stay under the radar for long. Scan these curated picks before the next potential breakout run leaves you watching from the sidelines.
-
Explore potential portfolio ballast by reviewing the 6 dividend fortresses , selected for investors who want income potential while prices remain at levels some may view as attractive.
-
Follow developments in digital finance through the 18 cryptocurrency and blockchain stocks , where curated blockchain-related opportunities may still be less widely followed.
-
Review the evolving energy build out using the 42 power grid technology and infrastructure stocks , a focused set of infrastructure stocks screened for those interested in long term electrification trends.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
